International journal of laboratory hematology

01 14 October 2026

DOI 10.1111/ijlh.70263

Performance Evaluation of an Artificial Intelligence‐Assisted Digital Morphology System for Bone Marrow Aspirate Examination

Open DOI

S. Urrutia Iñigo, J. R. Furundarena Salsamendi, A. Uranga Aguirregomezcorta et al.

Introduction: Morphological examination of bone marrow aspirates (BMA) remains essential for the diagnosis of hematologic diseases, but conventional microscopy is labor‐intensive and subject to interobserver variability. Methods: A total...

Read abstract

02 11 October 2026

DOI 10.1111/ijlh.70260

Smoking‐Related Distortion of Haemoglobin Concentration May Alter Anaemia Classification and Population Burden Estimates

Open DOI

Renjie Huang, Miao Huang, Rui Zhang

Introduction: Cigarette smoking can alter interpretation of measured haemoglobin near anaemia thresholds. We quantified the consequences of applying the World Health Organization (WHO) smoking adjustment. Methods: We analysed National He...

Read abstract

03 11 October 2026

DOI 10.1111/ijlh.70258

Challenge in the Laboratory Diagnosis of Acquired Factor VIII Inhibitor With Concurrent Lupus Anticoagulant: A Case Report

Open DOI

Chase V. West, Lindsey L. Farmer, Yu Yang et al.

04 9 October 2026

DOI 10.1111/ijlh.70256

Comprehensive Multicenter Evaluation of an AI ‐Based Deep Learning System for Automated Blood Cell Classification and Morphologic Analysis

Open DOI

Mendamar Ravzanaadii, Yuki Horiuchi, Kayoko Nakanishi et al.

Background and Objectives: Deep learning‐based systems have shown promise in automating white blood cell (WBC) classification; however, most validations are limited to single institutions. This study aimed to evaluate the multicenter per...

Read abstract

05 7 October 2026

DOI 10.1111/ijlh.70259

BCMA Antigen Loss Through Acquired TNFRSF17 Deletion in Multiple Myeloma

Open DOI

Ali Benaboud, Rémi Tilmont, Gauthier Decool et al.

06 6 October 2026

DOI 10.1111/ijlh.70257

Direct Oral Anticoagulant–Calibrated Heparin LRT Assay as a Rapid Alternative to an Anti‐Factor Xa Assay for Measuring Apixaban, Edoxaban, and Rivaroxaban in Patients With Non‐Valvular Atrial Fibrillation

Open DOI

Kwang‐Sook Woo, Dae‐Hyun Kim, Jong‐Sung Park et al.

07 30 September 2026

DOI 10.1111/ijlh.70254

VEXAS Syndrome Associated With a Non‐Canonical UBA1 p. Ala478Ser Variant: Diagnostic and Clinical Implications

Open DOI

Ilaria Scarpelli, Mario Uhr, Leda Leoncini et al.

08 25 September 2026

DOI 10.1111/ijlh.70253

Comparison of the HemoScreen Point‐Of‐Care Haematology Analyser With Sysmex XN , Beckman Coulter DxH 560 and HORIBA Yumizen H550 in Patients With Abnormal Blood Counts

Open DOI

Katarína Hradská, Martin Pulcer, Michaela SkořUpová et al.

Introduction: HemoScreen is a portable point‐of‐care testing (POCT) haematology analyser capable of measuring 20 complete blood count (CBC) parameters, including a 5‐part leukocyte differential, from venous and capillary blood. This stud...

Read abstract

09 23 September 2026

DOI 10.1111/ijlh.70252

Differentiating β‐Thalassaemia From Iron Deficiency: Performance and Cut‐Off Dependency of More Than 40 Red Cell Discrimination Indices in a Large German Cohort

Open DOI

Rafid Al‐Nabhan, Dani Hakimeh, Lena Oevermann

Background: Since the 1970s, more than 40 red blood cell–based formulas have been proposed to differentiate β‐thalassaemia trait (BTT) from iron deficiency (ID) and iron deficiency anaemia (IDA), the main causes of microcytic anaemia. In...

Read abstract

10 22 September 2026

DOI 10.1111/ijlh.70248

Adding‐On Wisely: Hematopathology Reflective Testing in Canada

Open DOI

Eric McEvoy, Eileen R. McBride

Introduction: Reflective testing describes laboratory clinicians' discretionary addition of testing on existing samples, after initial result review. This practice has proven valuable in clinical biochemistry but faces controversy regard...

Read abstract